Skip to content

The Policy Vault

Methodology Why Contact

Coverage / Highmark / Yargesa Miglustat

Yargesa Miglustat — Highmark

3 indications indexed for this drug.

Mild To Moderate Type 1 Gaucher Disease
View coverage criteria
Neurological Complications Of Niemann Pick Disease Type C Np
View coverage criteria
Niemann Pick Disease Type C Npc
View coverage criteria

The Policy Vault

Structured prior authorization and step-therapy criteria for commercial health plans. Built by pharmacists for healthcare professionals.

Disclaimer: Educational use only. Coverage varies by employer group and formulary. Always verify with the plan.

Product

Coverage Directory
Why Policy Vault
Methodology

Company

Contact
Press
Support

© 2025 The Policy Vault. Data sourced from official health plan documents.